Credit Agricole
BIO icon

Credit Agricole’s Bio-Rad Laboratories Class A BIO Stock Holding History

Credit Agricole’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$30.9K Sell
127
-680
-84% -$205K ﹤0.01% 1179
2024
Q4 		$265K Buy
807
+182
+29% +$61.8K ﹤0.01% 1103
2024
Q3 		$209K Sell
625
-116
-16% -$36.8K ﹤0.01% 1067
2024
Q2 		$202K Sell
741
-530
-42% -$154K ﹤0.01% 925
2024
Q1 		$357K Buy
1,271
+679
+115% +$223K ﹤0.01% 700
2023
Q4 		$191K Buy
592
+396
+202% +$124K ﹤0.01% 708
2023
Q3 		$70.3K Buy
+196
New +$75.6K ﹤0.01% 762
2017
Q2 		– Sell
-2,000
Closed -$399K – 1430
2017
Q1 		$399K Buy
+2,000
New +$385K ﹤0.01% 1422
2014
Q4 		– Sell
-6,312
Closed -$716K – 1570
2014
Q3 		$716K Hold
6,312
– – ﹤0.01% 1154
2014
Q2 		$756K Buy
+6,312
New +$771K ﹤0.01% 1162
2014
Q1 		– Sell
-700
Closed -$87K – 1552
2013
Q4 		$87K Sell
700
-700
-50% -$85.3K ﹤0.01% 1384
2013
Q3 		$165K Buy
+1,400
New +$165K ﹤0.01% 1339

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Credit Agricole's BIO Position: Q1 2025 in Review

Credit Agricole reduced its Bio-Rad Laboratories Class A (BIO) stake by 84% in Q1 2025, selling an estimated $205K and leaving 127 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Credit Agricole first reported a position in BIO in Q3 2013 and has held it in 12 quarters since. The position peaked at $756K in Q2 2014. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Credit Agricole held 127 shares of Bio-Rad Laboratories Class A worth $30.9K as of Q1 2025.
  • Credit Agricole sold 680 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $205K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1179 holding.
  • Credit Agricole first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and has held it in 12 quarters since.
  • Credit Agricole's Bio-Rad Laboratories Class A position peaked at $756K in Q2 2014.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.